Zymeworks (ZYME) Cash from Operations Growth (1y) (2022 - 2026)
Zymeworks (ZYME) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Zymeworks |
1.73 Bn |
1.36 Bn |
- |
-1,241.88% |
| Date | Value |
|---|
| Mar 31, 2026 |
-1,241.88% |
| Dec 31, 2025 |
75.29% |
| Sep 30, 2025 |
-434.22% |
| Jun 30, 2025 |
148.31% |
| Mar 31, 2025 |
90.96% |
| Dec 31, 2024 |
-397.93% |
| Sep 30, 2024 |
86.22% |
| Jun 30, 2024 |
-290.58% |
| Mar 31, 2024 |
54.71% |
| Dec 31, 2023 |
-95.74% |
| Sep 30, 2023 |
41.56% |
| Jun 30, 2023 |
88.33% |
| Mar 31, 2023 |
-50.13% |
| Dec 31, 2022 |
748.12% |
